UBS Maintains Buy on Oracle, Lowers Price Target to $245

Benzinga Newsdesk www.benzinga.com Negative 84.5%

Neg 84.5% Neu 0% Pos 0%

UBS analyst Karl Keirstead maintains Oracle (NYSE:ORCL) with a Buy and lowers the price target from $285 to $245.

Comments

No comments yet. Be the first!